These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37497824)

  • 1. Reduced 2,4-dienoyl-CoA reductase 1 is served as an unfavorable biomarker and is related to immune infiltration in cervical cancer.
    Guo S; Jiang H; Deng Y; Dong Y; Yin A; Wang Q; Lan Q; Zhang Y; Xu C
    J Obstet Gynaecol Res; 2023 Oct; 49(10):2475-2486. PubMed ID: 37497824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the expression of Stathmin and tumor immune cell infiltration in primary cervical carcinoma and its prognostic diagnostic value.
    Yang H; Li H; Tang X; Zhang J; Zhang X
    Heliyon; 2023 Dec; 9(12):e22585. PubMed ID: 38089980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of an immune infiltration landscape based on immune-related genes in cervical cancer.
    Yang Y; Wang N; Shi X; Wang Y; Yang C; Fan J; Jia X
    Comput Biol Med; 2022 Jul; 146():105638. PubMed ID: 35605489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
    Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
    Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive bioinformatics analysis of the expression, prognostic value, and immune infiltration of chromobox family members in cervical cancer.
    Liao D; Liu X; He L; Yao Y; Yuan X; Feng P; Li C; Liu Y
    Iran J Basic Med Sci; 2023 Apr; 26(4):468-477. PubMed ID: 37009012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key biomarkers and related immune cell infiltration in cervical cancer tissue based on bioinformatics analysis.
    Zhu G; Xiong Z; Chen W; Zhu Z; Wang W
    Sci Rep; 2023 Jun; 13(1):10121. PubMed ID: 37344577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures.
    Wang N; Nanding A; Jia X; Wang Y; Yang C; Fan J; Dong A; Zheng G; Ma J; Shi X; Yang Y
    Front Immunol; 2022; 13():993118. PubMed ID: 36341424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Expression of RTN1 in Lung Adenocarcinoma and 
Its Effect on Immune Microenvironment].
    Zhu S; Zu L; Xu S
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma.
    Guo F; Kong WN; Li DW; Zhao G; Wu HL; Anwar M; Shang XQ; Sun QN; Ma CL; Ma XM
    Technol Cancer Res Treat; 2022; 21():15330338221106530. PubMed ID: 35730194
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
    Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.
    Huo X; Shen G; Li J; Wang M; Xie Q; Zhao F; Ren D; Dong Q; Zhao J
    Gene; 2022 Feb; 812():146094. PubMed ID: 34896519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
    Zhang YH; Zeng J; Liu XS; Gao Y; Kui XY; Liu XY; Zhang Y; Pei ZJ
    Front Endocrinol (Lausanne); 2022; 13():1013238. PubMed ID: 36299451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 17. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
    Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
    Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
    Huang ZY; Liao PJ; Liu YX; Zhong M; Sun AH; Jiang XC; Wang XP; Zhang M
    Bioengineered; 2021 Dec; 12(1):5739-5748. PubMed ID: 34516350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.